Skip to main content

Developing New Contraceptives Obstacles and Opportunities (1990) / Chapter Skim
Currently Skimming:

1 Introduction
Pages 7-10

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 7...
... Outside the United States, particularly in developing countries where medical services appropriate for the diagnosis and treatment of contraceptive-related side effects are limited and where the health risks of pregnancy, labor, and delivery are much greater than in the United States, there is also a great deal of concern about people's ability to use existing contraceptive methods to meet their varying needs for safe, effective, and acceptable fertility control. The costs of unwanted pregnancies and childbirth for mothers and children, as well as for their families and the communities in which they live, can be very high.
Read the entire page →
From page 8...
... Err L_ ._ ^L ~ ~.~ ,¢ ,_ __ W i; llvpe trials report Will oe read by the people who directly or indirectly shape contraceptive development policy in the United States. Three groups seem particularly important in this regard.
Read the entire page →
From page 9...
... The chapter reviews the efforts of the FDA to balance risks and benefits to individuals and society and examines recent changes in the regulation of contraceptive products. A number of specific issues related to the regulation of contraceptives in the United States and with relations between American and foreign regulatory agencies are also discussed.
Read the entire page →
From page 10...
... The report concludes with a glossary to help readers who are unfamiliar with specific technical terms. There are no quick fixes to the problems caused by the limited range of contraceptive methods available to men and women in the United States and to millions of other men and women around the world.
Read the entire page →

Key Terms

  • contraceptive products
  • contraceptive methods
  • products liability
  • fertility control
  • organizations involved

  • contraceptive research
  • specific issues
  • governing work
  • led specialists
  • medical services

  • development enterprise
  • pharmaceutical firms
  • trials report
  • includes people
  • committee collected

  • significant influences
  • public attitudes
  • enable readers
  • existing contraceptive
  • address specific

  • nonprofit organizations
  • methods available
  • values related
  • limited range
  • acceptable fertility

  • reviewed data
  • contraceptive technology
  • services appropriate
  • health risks
  • broad public


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.